DETAILS, FICTION AND CLINICAL EFFECTIVENESS OF ABBV-744 IN AML PATIENTS

In Section A, individuals will receive various doses and schedules of oral ABBV-744 pill to establish Safe and sound dosing routine. Extra participants will be enrolled within the discovered monotherapy dosign routine. In Phase B, members will receive oral ruxolitinib and ABBV-744 will be specified as "incorporate-on" therapy. In Segment C, members